Protects Against UV & Pollution Damage Strengthens skin barrier and prevents oxidative stress
Gain critical insights on BPCIA, patent strategies, and future litigation
212,213 The ongoing SURPASS-CVOT trial (NCT04255433) and SURPASS-CVOT trial (NCT06779929) aim to evaluate the impact of tirzepatide on cardiovascular outcomes compared with dulaglutide in patients with type 2 diabetes
Table of Contents Why 2026 Is Different: The GLP-1 Revolution Meets Nutritional Science The Missing Piece: Why GLP-1 Patients Need RDN Support How RDNs Make Weight Loss Resolutions Stick The Growing Demand: Career Opportunities for Nutrition Professionals Educational Pathways: Becoming a GLP-1 Nutrition Specialist Real-World Application: What GLP-1 Nutrition Counseling Looks Like Frequently Asked Questions Key Takeaways Why 2026 Is Different: The GLP-1 Revolution Meets Nutritional Science GLP-1 receptor agonists have fundamentally changed the conversation about weight loss
Although the two active forms have shown equal biological potency, the majority of circulating GLP-1 in humans is found in the amidated form
Many patients choose evening injections because they can observe any mild injection-site reactions while at home and before bed, when discomfort is less noticeable
